All data are based on the daily closing price as of June 6, 2025
h
Hanmi Science Co.
008930.KO
27.25 USD
1.40
+5.42%
Overview
Last close
27.25 usd
Market cap
1.85B usd
52 week high
41.84 usd
52 week low
17.04 usd
Target price
23.82 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.9462
Price/Book Value
2.9526
Enterprise Value
1.94B usd
EV/Revenue
2.0494
EV/EBITDA
34.9819
Key financials
Revenue TTM
948.42M usd
Gross Profit TTM
197.30M usd
EBITDA TTM
27.49M usd
Earnings per Share
N/A usd
Dividend
0.22 usd
Total assets
924.86M usd
Net debt
N/A usd
About
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.